期刊文献+

放射治疗在不同肿瘤治疗中的变化 被引量:1

下载PDF
导出
摘要 放射治疗和各种肿瘤治疗手段一样,在不同肿瘤治疗中的地位有所变化。现对放射治疗作用有所下降的肿瘤以及放射治疗成为主要的治疗手段的肿瘤作一介绍。
作者 殷蔚伯
出处 《实用医院临床杂志》 2006年第1期7-8,共2页 Practical Journal of Clinical Medicine
  • 相关文献

参考文献7

  • 1李晔雄.胃黏膜相关淋巴瘤[J].中华放射肿瘤学杂志,2004,13(2):138-142. 被引量:2
  • 2李晔雄,姚波.鼻腔NK/T细胞淋巴瘤的临床病理特点及治疗[J].中华放射肿瘤学杂志,2004,13(3):172-176. 被引量:22
  • 3[3]Kalapurakal JA,Dome JS Perlman EJ et al.Management of Wilm's tumor:Current pratice and future goals[J].Lancet Oncology 2004,5 (1):37 ~ 46.
  • 4[4]Early Breast Cancer Trialists' Collaborative Group.Effects of radiotherapy and surgery in early breast cancer.An overview of the randomized trials [J].N Engl J Med,1995,333(22):1444 ~55.
  • 5[5]Uematsu U.Computed tomography(CT) guided stereotactic radiation therapy (SRT) for stage I non - small cell lung cancer (NSCLC) an 8 year results of initial 50 patients[C].ASTRO Abstract 2003.
  • 6[6]Timmerman RD,Papiez L,Mc Garry R,et al.Extracranial stereotactic radioablation:Results of a phase I study in stage I non small cell lung cancer[C].ASTRO Abstracts 2003.
  • 7[7]Macdonald JS,Smalley SR,Benedetti J et al.Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J].New Engl J Med,2001,345 :725 ~30.

二级参考文献39

  • 1Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B cell lymphoma. Cancer, 1983,52: 1410-1416.
  • 2Nathwani BN, Anderson JR, Armitage JO, et al. Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. J Clin Oncol, 1999, 17:2486-2492.
  • 3Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House,Virginia, November, 1997. Histopathology,
  • 4Zucca E, Roggero E. Biology and treatment of MALT lymphoma: the state-of-the-art in 1996: a workshop at the 6th international conference on malignant lymphoma. Ann Oncol, 1996, 7:787-792.
  • 5Liu H, Ruskone-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t( 11; 18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet, 2000, 357:39-40.
  • 6Nakamura S, Akazawa K, Kinukawa N, et al. Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum Pathol, 1996, 27:225-233.
  • 7Wotherspon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 1993, 342: 575-577.
  • 8Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lynphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet, 1995, 345: 1591-1594.
  • 9Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of nucosa-associated lymphoid tissue. Ann Intern Med, 1995, 122:767-769.
  • 10Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction,or both? Blood, 1996, 87:1255-1260.

共引文献22

同被引文献7

  • 1Bauman M,Apporl S,Petersen C, et al. Dose and fractionation con-cepts in the primary radiotherapy of non-small cell lung cancer[ J].Lung Cancer,2001,33(Supp 1) :S35.
  • 2Cheung PC,Yeung LT,Basrur V,et al. Accelerated hypofractionationfor early-stage non-small-cell lung cancer[ J] . Int J Radiat Oncol Bi-ol Phys,2002,54:1014-23.
  • 3Mehta M,Scrimger R,Mackie R,et al. A new approach to dose esca-lation in non-small-cell lung cacer[ J ]. Int J Radiat Oncol Biol Phys,2001,49:23-33.
  • 4Onishi M, Araki T, Shirato H, et al. Stereotactic hypo-fractionatedhi^i-dose irradiation for stage I non-small cell lung cancer: clinicaloutcomes in 245 subjects in a Japanese multi institutional study.[J]. Cancer,2004,101:1623-1631.
  • 5Yamashita H,Nakagawa K,Nakamura N,et al. Exception high inci-dence of symptomatic grade 2-5 radiation penumonitis after stereotac-tic radiation therapy for lung tumors[ J]. Radiat Oncol,2007,2 :21.
  • 6Milanl MT, Constine LS, Okunieff P. Normal tissue tolerance dosemetrics for radiation therapy of major organs[ J]. Semin Radiat On-col,2007 ,17 : 131-140.
  • 7Wemer-wasik M, Yorke E, Deasy J, et al. Radiation dose-volumeeffects in the esophagus[ J]. Int J Radiat Oncol Biol Phys,2009,76(3):86-92.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部